Novo Nordisk (NVO)
(Delayed Data from NYSE)
$143.07 USD
+0.70 (0.49%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $143.20 +0.13 (0.09%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum B VGM
Brokerage Reports
Novo Nordisk A/S [NVO]
Reports for Purchase
Showing records 141 - 160 ( 195 total )
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Company: Novo Nordisk A/S
Industry: Large Cap Pharmaceuticals
Industry Report ; PHARMA & BIOTECH; This report contains brief updates on the following: VRX, PFE, NVO, MNTA, CORT, BIIB, AMGN. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: ZACKS INVESTMENT RESEARCH